title: Patients' preferences towards antiepileptic drug therapy following first attack of seizure.
abstract: BACKGROUND
  Antiepileptic drug (AED) therapy following first unprovoked seizure is controversial.
  
  
  OBJECTIVE
  To study the patients' preferences towards AED therapy following first unprovoked generalized tonic clonic seizure (GTCS).
  
  
  METHODS
  Prospective cohorts with one year follow-up study.
  
  
  METHODS
  Government teaching hospital, a tertiary care center.
  
  
  METHODS
  Patient cohort included patients with first attack of unprovoked GTCS within 30 days of onset, aged between 18-60 years and with normal brain CT scan. Counseling was done for all the patients and the relatives regarding seizure recurrence, duration and adverse effects of AED therapy if preferred. Patients were encouraged to make their own decision in preferring or deferring AED with reasons. They were followed up for one year.
  
  
  RESULTS
  Of the 73 enrolled (54 males and 19 females) 39 (53%) preferred to go on AED therapy. The reasons for preferring AED therapy were; (a) fear of seizure recurrence, 21 (54%); (b) risky occupation, 14 (36%); and (c) fear of injury, 4 (10%). The reasons for deferring were: (a) fear of adverse effects of long-term AED therapy, 19 (56%) and (b) preferring to wait for the second attack, 15 (44%). All the patients were happy about being involved in the decision-making.
  
  
  CONCLUSIONS
  Following first attack of unprovoked GTCS the decision regarding AED therapy may be taken by the patients and their family members after adequate counseling and such decisions have more relevance from their perspective.
authors.affiliation: Department of Neurology, Government Stanley Medical College and Hospital, Chennai, India.
authors.forename: V
authors.initials: V
authors.lastname: Chandramoulesswaran
authors.forename: M
authors.initials: M
authors.lastname: Dhanaraj
authors.forename: R
authors.initials: R
authors.lastname: Rangaraj
authors.forename: A
authors.initials: A
authors.lastname: Vengatesan
mesh_terms: D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D015331:Cohort Studies; D004829:Epilepsy, Generalized / Q000188:drug therapy*; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011446:Prospective Studies; D014057:Tomography, X-Ray Computed
chemical_list: D000927:Anticonvulsants